Sulfonylurea Is Associated With Higher Risks of Ventricular Arrhythmia or Sudden Cardiac Death Compared With Metformin: A Population-Based Cohort Study.

MLA

Lee, Teddy Tai Loy, et al. “Sulfonylurea Is Associated With Higher Risks of Ventricular Arrhythmia or Sudden Cardiac Death Compared With Metformin: A Population-Based Cohort Study.” Journal of the American Heart Association, vol. 11, no. 18, Sept. 2022, p. e026289. EBSCOhost, https://doi.org/10.1161/JAHA.122.026289.

APA

Lee, T. T. L., Hui, J. M. H., Lee, Y. H. A., Satti, D. I., Shum, Y. K. L., Kiu, P. T. H., Wai, A. K. C., Liu, T., Wong, W. T., Chan, J. S. K., Cheung, B. M. Y., Wong, I. C. K., Cheng, S. H., & Tse, G. (2022). Sulfonylurea Is Associated With Higher Risks of Ventricular Arrhythmia or Sudden Cardiac Death Compared With Metformin: A Population-Based Cohort Study. Journal of the American Heart Association, 11(18), e026289. https://doi.org/10.1161/JAHA.122.026289

Chicago

Lee, Teddy Tai Loy, Jeremy Man Ho Hui, Yan Hiu Athena Lee, Danish Iltaf Satti, Yuki Ka Ling Shum, Pias Tang Hoi Kiu, Abraham Ka Chung Wai, et al. 2022. “Sulfonylurea Is Associated With Higher Risks of Ventricular Arrhythmia or Sudden Cardiac Death Compared With Metformin: A Population-Based Cohort Study.” Journal of the American Heart Association 11 (18): e026289. doi:10.1161/JAHA.122.026289.